English | 简体中文 | LP ACCESS

About artrix

This author has not yet filled in any details.
So far artrix has created 54 blog entries.

Neurogastrx Secures $60 Million in Series B Financing and Expands Management Team to Advance Its Pipeline of Transformative Investigational Therapies for Gastrointestinal Disorders

Neurogastrx Secures $60 Million in Series B Financing and Expands Management Team to Advance Its Pipeline of Transformative Investigational Therapies for Gastrointestinal Disorders2021-08-28T22:50:11-07:00

World Health Organization (“WHO”) Authorizes a Vivo Portfolio Company Sinovac Biotech, for Emergency Use

World Health Organization (“WHO”) Authorizes a Vivo Portfolio Company Sinovac Biotech, for Emergency Use2021-06-01T20:08:19-07:00

Vivo Capital’s venture portfolio company AADI announces a merger agreement with Aerpio Pharmaceuticals with a concurrent $155M in PIPE financing by Aerpio Pharmaceuticals

Vivo Capital’s venture portfolio company AADI announces a merger agreement with Aerpio Pharmaceuticals with a concurrent $155M in PIPE financing by Aerpio Pharmaceuticals2021-05-22T13:33:43-07:00

Palo Alto
Global Headquarters

Beijing
 

Shanghai 
 

Taipei  
 

Hong Kong   
 

Email: info@vivocapital.com
Vivo Capital®, SEC registered, effective 6/19/2014. All rights reserved.
Go to Top